Gene: RASGRF2
Official Full Name: Ras protein specific guanine nucleotide releasing factor 2provided by HGNC
Gene Summary: RAS GTPases cycle between an inactive GDP-bound state and an active GTP-bound state. This gene encodes a calcium-regulated nucleotide exchange factor activating both RAS and RAS-related protein, RAC1, through the exchange of bound GDP for GTP, thereby, coordinating the signaling of distinct mitogen-activated protein kinase pathways. [provided by RefSeq, Oct 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO10514 | RASGRF2 Knockout cell line (HEK293) | Human | RASGRF2 | 1:3~1:6 | Negative | Online Inquiry |
KO10515 | RASGRF2 Knockout cell line (A549) | Human | RASGRF2 | 1:3~1:4 | Negative | Online Inquiry |
RASGRF2 Gene Knockout Cell Lines are specially engineered cellular models designed to investigate the functional role of the RASGRF2 gene, which encodes a guanine nucleotide exchange factor that activates RAS proteins. These cell lines have been created using precise genome editing techniques, such as CRISPR/Cas9, to produce specific knockouts, thereby allowing researchers to analyze the downstream effects of RASGRF2 loss on cellular signaling pathways, proliferation, and differentiation.
The key function of RASGRF2 involves its activation of the RAS-RAF-MEK-ERK signaling cascade, a critical pathway that regulates various cellular processes including growth, survival, and apoptosis. By utilizing these knockout cell lines, researchers can delineate the contributions of RASGRF2 in normal physiological processes as well as its implications in pathological conditions such as cancer and metabolic disorders. Moreover, these models serve as powerful tools in drug discovery, enabling scientists to test the efficacy of therapeutic compounds that target RAS signaling.
One of the primary advantages of using RASGRF2 Gene Knockout Cell Lines is the specificity and precision of the genetic modification, which allows for reproducible and reliable results compared to traditional knockout methods. This targeted approach minimizes off-target effects, enhancing the accuracy of experimental outcomes. Furthermore, the availability of these specialized cell lines provides a clear alternative to transient transfection methods, facilitating long-term studies on gene function without the hassle of transient expression variability.
For researchers and clinicians, the ability to wield these precise knockout models empowers them to gain deeper insights into RAS biology, paving the way for novel therapeutic interventions. The elucidation of the RASGRF2 pathway can potentially lead to breakthroughs in targeted therapies for various diseases characterized by dysregulated RAS signaling.
Our company is dedicated to advancing biological research by providing high-quality, specialized tools such as the RASGRF2 Gene Knockout Cell Lines. With a commitment to scientific excellence and innovation, we strive to support researchers in uncovering the complexities of gene function and their broader applications in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.